http://www.reuters.com/article/brief-shenzhen-hepalink-pharmas-2016-net-idUSH9N1HY04V
Shenzhen Hepalink Pharmaceutical Co Ltd
* Says 2016 net profit down 31.5 percent y/y at 396.9 million yuan ($57.59 million)
* Says trading in shares to halt from April 28 pending announcement related to asset acquisition
Source text in Chinese: bit.ly/2ozwmGQ ; bit.ly/2ozub6d
Further company coverage: ($1 = 6.8920 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)